Authors:
VANVLIET IM
WESTENBERG HGM
SLAAP BR
DENBOER JA
PIAN KLH
Citation: Im. Vanvliet et al., ANXIOGENIC EFFECTS OF PENTAGASTRIN IN PATIENTS WITH SOCIAL PHOBIA ANDHEALTHY CONTROLS, Biological psychiatry, 42(1), 1997, pp. 76-78
Authors:
SLAAP BR
VANVLIET IM
WESTENBERG HGM
DENBOER JA
Citation: Br. Slaap et al., MHPG AND HEART-RATE AS CORRELATES OF NONRESPONSE TO DRUG-THERAPY IN PANIC DISORDER PATIENTS - A PRELIMINARY-REPORT, Psychopharmacology, 127(4), 1996, pp. 353-358
Authors:
DELEEUW AS
DENBOER JA
SLAAP BR
WESTENBERG HGM
Citation: As. Deleeuw et al., PENTAGASTRIN HAS PANIC INDUCING PROPERTIES IN OBSESSIVE-COMPULSIVE DISORDER, Psychopharmacology, 126(4), 1996, pp. 339-344
Authors:
VANVLIET IM
SLAAP BR
WESTENBERG HGM
DENBOER JA
Citation: Im. Vanvliet et al., BEHAVIORAL, NEUROENDOCRINE AND BIOCHEMICAL EFFECTS OF DIFFERENT DOSESOF 5-HTP IN PANIC DISORDER, European neuropsychopharmacology, 6(2), 1996, pp. 103-110
Authors:
VANVLIET IM
DENBOER JA
WESTENBERG HGM
SLAAP BR
Citation: Im. Vanvliet et al., A DOUBLE-BLIND COMPARATIVE-STUDY OF BROFAROMINE AND FLUVOXAMINE IN OUTPATIENTS WITH PANIC DISORDER, Journal of clinical psychopharmacology, 16(4), 1996, pp. 299-306
Authors:
SLAAP BR
VANVLIET IM
WESTENBERG HGM
DENBOER JA
Citation: Br. Slaap et al., RESPONDERS AND NONRESPONDERS TO DRUG-TREATMENT IN SOCIAL PHOBIA - DIFFERENCES AT BASE-LINE AND PREDICTION OF RESPONSE, Journal of affective disorders, 39(1), 1996, pp. 13-19
Authors:
DENBOER JA
VANMEGEN HJGM
FLEISCHHACKER WW
LOUWERENS JW
SLAAP BR
WESTENBERG HGM
BURROWS GD
SRIVASTAVA ON
Citation: Ja. Denboer et al., DIFFERENTIAL-EFFECTS OF THE D1-DA RECEPTOR ANTAGONIST SCH139166 ON POSITIVE AND NEGATIVE SYMPTOMS OF SCHIZOPHRENIA, Psychopharmacology, 121(3), 1995, pp. 317-322
Authors:
SLAAP BR
VANVLIET IM
WESTENBERG HGM
DENBOER JA
Citation: Br. Slaap et al., PHOBIC SYMPTOMS AS PREDICTORS OF NONRESPONSE TO DRUG-THERAPY IN PANICDISORDER PATIENTS (A PRELIMINARY-REPORT), Journal of affective disorders, 33(1), 1995, pp. 31-38